ArticleTherapeutic advances in infectious disease

Acceptability of a new 4-in-1 Abacavir/Lamivudine/Lopinavir/Ritonavir paediatric fixed-dose combination: the caregiver-child dyads' perspective.

Anke Rotsaert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.